Optegra, the UK’s second largest private ophthalmology group, has bought a new clinic in Yorkshire, bringing its total number of facilities across the country to 25.
The UK branch of British multinational healthcare company Bupa is launching a new direct-to-consumer subscription service for primary care, giving customers access to same-day appointments with a private GP, starting at just over £200 per year.
Over the coming years and decades an increasing amount of care will be delivered to patients in their homes. New devices and wearables that can collect health data from people whilst they’re at home and healthcare’s digitalisation trend are opening up new possibilities, both for prevention and for providing better and more efficient care to those with chronic conditions.
UCB, a Belgian biopharma company, plans to divest its business in China, to CBC Group, a Singapore-based investment firm, and Mubadala, a global investment company from Abu Dhabi, for $680 million.
The deal, pending regulatory approval, is expected to close in Q4 2024 and includes UCB’s neurology and allergy portfolios, as well as its manufacturing site in Zhuhai, China.
The UK’s Department of Health and Social Care (DHSC), NHS England, and the Association of the British Pharmaceutical Industry (ABPI) have launched a £400 million initiative to improve the country’s pharmaceutical testing capabilities.
Termed the ‘Voluntary Scheme for Branded Medicine Pricing, Access and Growth’ (VPAG), this public-private investment will create up to 18 new clinical trial hubs across the UK, speeding up the development and availability of new medicines, as detailed in the August 28 press release.
Warburg Pincus, a global private equity firm based in New York, exited Indian pharmacy chain MedPlus Health Services on August 26, selling its entire 11.4% stake for approximately $100 million through an open market transaction. The sale was carried out by its Mauritius-based unit, Lavender Rose Investment Ltd.
Affidea Group, a pan-European diagnostics and specialist healthcare provider headquartered in the Netherlands, has signed a binding agreement to acquire Nu-Med, a Polish cancer care group, from Polish PE firm Enterprise Investors.
Zerenia Clinic is a UK-based private healthcare provider specialising in treatments with cannabis-based medicinal products (CBMP). Last year it attained the UK’s first ever NHS reimbursement for cannabis flowers. In an interview with HBI, Dr. Guillermo Moreno-Sanz, Scientific Director at Zerenia’s parent company, Khiron Europe (a pharma company producing CBMPs), spoke about the growing opportunity in Europe’s medicinal cannabis space.
Modern hospitals are incredibly complex, regularly chaotic, and often inefficient environments, despite efficiency and proper task sequencing being vital to delivering high-quality medical care and positive patient experiences. Workforce issues are beginning to bite harder across both public and private provider systems, driven by a growing deficit in medical professionals serving an expanding patient population. […]
CVC Capital Partners, a Luxembourg-based private equity firm, has acquired an additional 45% stake in Indonesia's chain of multi speciality hospitals, Siloam Hospitals, from the country’s conglomerate Lippo Karawaci for 16.6 trillion rupiah ($1 billion), making CVC the majority shareholder. This transaction, involving 5.85 billion shares, was announced on the Indonesia Stock Exchange.
Healthcare Business International users cookies to improve the functionality, performance, and effectiveness of our communications. Detailed information on the use of cookies is provided in our Cookies Policy. By continuing to use this site, or by clicking "I agree" you consent to the use of cookies.OkCookies Policy
